Molecular Partners Presents Preclinical Data Supporting Tumor Localization Mechanism of its CD40 Agonist MP0317 at World Bispecific Summit

September 24, 2020 12:00 PM

MP0317 activates multiple antitumor immune cell types in vitro when in the presence of tumor stroma associated FAP MP0317 mouse surrogate localizes to FAP-expressing tumors and induces strong and durable anti-tumor responses without systemic toxicity, and demonstrates strong anti-tumor immune memory responses ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / September 24, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech...

Read more

OPTEC International, Inc. (OPTI) Secures $5,000,000 + Financing for Expansion of UV-C Sterilization Products to Help Safely Re-Open Economy Amidst Increased Pandemic Case Reports

September 24, 2020 8:00 AM

CARLSBAD, CA / ACCESSWIRE / September 24, 2020 / OPTEC International, Inc (OTC PINK:OPTI) today announced that it has secured a $5,000,000+ funding approval with California based RB Capital Partners, Inc. ("RB Capital"). RB Capital has agreed to provide funding to the Company in the form of premium to market 12 month promissory notes. The minimum amount of funding that RB Capital has agreed to provide to the Company under these terms...

Read more

Integrated BioPharma Reports Results for its Fiscal Year Ended June 30, 2020

September 23, 2020 5:25 PM

HILLSIDE, NJ / ACCESSWIRE / September 23, 2020 / Integrated BioPharma, Inc. (OTCQB:INBP) (the "Company" or "INBP") reports its financial results for the fiscal year ended June 30, 2020. Revenues for the fiscal year ended June 30, 2020 were $52.8 million compared to $50.0 million for the fiscal year ended June 30, 2019, an increase of $2.8 million or 5.6%. The Company had operating income for the fiscal year ended June 30,...

Read more

Yulong to List its Securitized Token on CryptoSX

September 23, 2020 8:35 AM

CHEYENNE, WY / ACCESSWIRE / September 23, 2020 / Yulong Eco-Materials Limited / EV Biologics, Inc. (OTC PINK:YECO) today announced that it intends to list its Securitized Token Offering "STO" on the CryptoSX digital exchange. CryptoSX is a fully licensed and regulated Digital Assets Exchange that allows issuers to tokenize and investors to buy and sell digital assets including assisting issuers to securitize assets, such as public...

Read more

Nascent Biotech Research Collaboration Partner, Manhattan BioSolutions, Receives Grant for Covid 19 Vaccine Studies.

September 23, 2020 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / September 23, 2020 / Nascent Biotech, Inc (OTCQB:NBIO), a biotechnology company pioneering innovative medicines to overcome difficult-to-treat cancers and viral infections, announces that its collaboration partner, Manhattan BioSolutions, has been awarded a Phase I SBIR grant by the National Science Foundation (NSF) entitled "Genetically Engineered BCG as a Microbe-Based Platform for Vaccination Against...

Read more

Mymetics Starts Preclinical Studies with Baylor College of Medicine for Virosome-based Covid-19 Vaccine

September 23, 2020 6:00 AM

Mymetics has started a Covid-19 vaccine development project based on Mymetics' virosome vaccine carrier platform, which will evaluate different rationally designed SARS-CoV-2 antigens for an effective and safe virosome-based Covid-19 vaccine. In May 2020 Mymetics and Baylor College of Medicine in Texas signed a Research Agreement to preclinically produce and test virosomes incorporating SARS-CoV-2 recombinant proteins. As part of the...

Read more

American CryoStem Announces: FDA has cleared its Investigational New Drug (IND) for Post-Concussion Syndrome for Phase I Clinical Trial

September 23, 2020 6:00 AM

EATONTOWN, NJ / ACCESSWIRE / September 23, 2020 / American CryoStem Corporation (OTC PINK:CRYO) is a clinical stage biotechnology company, global licensor, and a pioneer in autologous cellular therapy processing. The Company has developed proprietary products and services to advance its end-to-end personalized cellular therapy platform consisting of the collection - processing - cryobanking - return to point-of-care of adipose tissue and...

Read more

Wuhan General Group Corporate Update on Tsime Pharmaceuticals Acquisition

September 22, 2020 9:05 AM

CAPE TOWN, SA / ACCESSWIRE / September 22, 2020 / WUHAN GENERAL GROUP, INC. (WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is delighted to share the following corporate updates: Tsime Pharmaceuticals The last step in completing the due diligence regarding the acquisition of Tsime Pharmaceuticals Inc. ("Tsime") was...

Read more

Applied UV, Inc. Subsidiary, SteriLumen, Inc., Announces Receipt of Purchase Order for Airocide(TM) Air Quality-Improvement(TM) System from Dubai Creek Golf & Yacht Club Resort

September 22, 2020 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / September 22, 2020 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") utilizing its patented devices to destroy pathogens safely, thoroughly, and automatically, today announced that its subsidiary, SteriLumen, Inc. ("SteriLumen"), together with its...

Read more

OPTEC International, Inc. (OPTI) Introduces UV & UV-C Hydroxyl Air Purifier Solutions for Commercial and Personal Applications

September 22, 2020 8:00 AM

CARLSBAD, CA / ACCESSWIRE / September 22, 2020 / OPTEC International, Inc (OTC PINK:OPTI) today announced that the Company now has a suite of air purification products that effectively kills 99.99% of virus, bacteria, germs, and other harmful contaminants based on SGS testing (the world's leading inspection, verification, testing and certification company). Specifically, the Optec Hydroxyl Air Sterilizer is safe to use while children and...

Read more

Aqualung Therapeutics Corp. Awarded $300 Thousand From National Institute of Health (NIH) to Develop a Novel Therapeutic for Pregnant Women at Risk for Preterm Births

September 22, 2020 7:45 AM

TUCSON, AZ / ACCESSWIRE / September 22, 2020 / Aqualung Therapeutics, an early-stage biotech company developing an immune-focused, anti-inflammatory therapeutic platform for unchecked inflammation in patients with serious acute and chronic diseases, has been awarded a one year NIH FAST-TRACK AWARD (1R41 HD101202-01A1) to support development of a humanized antibody therapy for pregnant women with intrauterine infection at risk for preterm...

Read more

Experion Partners with Leading National Sales Agency, Velvet Management

September 21, 2020 8:45 AM

VANCOUVER, BC / ACCESSWIRE / September 21, 2020 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce a partnership with Velvet Management Inc. ("Velvet"), to be its national sales and distribution agent for its premium craft cannabis brand, Citizen Stash, to be sold through provincially licensed stores across Canada. Velvet is a leading full-service...

Read more

Yulong to Issue the Worlds’ First Biotech Securitized Token Offering

September 21, 2020 8:30 AM

CHEYENNE, WY / ACCESSWIRE / September 21, 2020 / Yulong Eco-Materials Limited / EV Biologics, Inc. (OTC:YECO) today announced that it intends to issue a Securitized Token Offering "STO" to raise funding for research and development - a world's first. Security Token Offering (STO) YECO/EV Biologics is preparing to launch the first ever Securitized Token for cell-based therapy/biological drug development. This move will...

Read more

Hancock Jaffe Announces Positive Nasdaq Listing Determination

September 21, 2020 8:30 AM

Extension Granted for Continued Listing IRVINE, CA / ACCESSWIRE / September 21, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Company has received formal notification that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Capital Market pursuant to an...

Read more

Pieris Pharmaceuticals Presents Updated Data from Phase 1 Monotherapy and Atezolizumab Combination Studies of 4-1BB/HER2 Bispecific PRS-343 at the European Society for Medical Oncology (ESMO) Virtual Congress 2020

September 20, 2020 11:00 AM

Clinical benefit in both trials, including one confirmed complete response and three partial responses in the monotherapy trial and four confirmed partial responses in the atezolizumab combination trial Robust durability of response in both trials, including more than 18 months in the combination trial Biomarker data, including substantial CD8+ T cell expansion and soluble 4-1BB increase, suggest 4-1BB-driven activity BOSTON, MA /...

Read more

Dr. Scott Brooks, Head of Food Safety at Tyson Foods, Joins Novalent Biotech’s Scientific Advisory Team

September 18, 2020 3:16 PM

GREENSBORO, NC / ACCESSWIRE / September 18, 2020 / Novalent Biotech, Inc (‘Novalent'), a US biotechnology engineering firm, has announced the appointment of Dr. Scott Brooks, Head of Food Safety at Tyson Foods, to Novalent's Scientific Advisory Board. Novalent has revolutionized food safety by developing a patented technology which provides a safe and protective antimicrobial layer on surfaces that continuously inhibits the...

Read more

DECN Announces Finalizing of International Genviro! COVID-19 Saliva Swift Kits for Global Market and Establishes Introductory Sales Pricing

September 18, 2020 9:15 AM

LOS ANGELES, CA / ACCESSWIRE / September 18, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., today announced it is finalizing its Covid-19 Saliva Swift Kits for international use along with its recommended pricing for the global market....

Read more

Pardeep Nijhawan Acquires Beneficial Ownership of Additional Securities of Edesa Biotech, Inc.

September 18, 2020 8:10 AM

MARKHAM, ON / ACCESSWIRE / September 18, 2020 / Dr. Pardeep Nijhawan ("Dr. Nijhawan") announces that his beneficial ownership of common shares ("Common Shares") in the capital of Edesa Biotech, Inc. ("Edesa") has increased by more than 2% of the issued and outstanding Common Shares from the amount reported in the early warning report Dr. Nijhawan filed dated May 11, 2020 (the "Previous Report"). The...

Read more

Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development

September 17, 2020 8:30 AM

LIANYUNGANG, CHINA and JUPITER, FL / ACCESSWIRE / September 17, 2020 / Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced collaboration with Jiangsu Hengrui Medicine Co.,...

Read more

Applied UV, Inc. Subsidiary, SteriLumen, Inc. Installs First Ultraviolet Light Disinfecting Devices at Mt. Sinai St. Luke's Hospital as Part of Evaluation Study

September 17, 2020 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / September 17, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") utilizing its patented devices to destroy pathogens safely, thoroughly, and automatically, today announced that its subsidiary, SteriLumen, Inc. ("SteriLumen"), has installed its...

Read more